G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 100.6 INR -2.89% Market Closed
Market Cap: 134.9B INR

Intrinsic Value

The intrinsic value of one GLS stock under the Base Case scenario is 718.3 INR. Compared to the current market price of 1 100.6 INR, Glenmark Life Sciences Ltd is Overvalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GLS Intrinsic Value
718.3 INR
Overvaluation 35%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
Glenmark Life Sciences Ltd

GLS
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for GLS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Glenmark Life Sciences Ltd
NSE:GLS
IN
Pharmaceuticals
Market Cap
134.9B INR
IPO
Aug 6, 2021
IN
Pharmaceuticals
Market Cap
134.9B INR
IPO
Aug 6, 2021
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GLS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Glenmark Life Sciences Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Glenmark Life Sciences Ltd

Current Assets 21B
Cash & Short-Term Investments 5.3B
Receivables 7.8B
Other Current Assets 7.9B
Non-Current Assets 9.9B
Long-Term Investments 111.2m
PP&E 9.5B
Intangibles 172.7m
Other Non-Current Assets 152.9m
Efficiency

Free Cash Flow Analysis
Glenmark Life Sciences Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Glenmark Life Sciences Ltd

Revenue
22B INR
Cost of Revenue
-9.9B INR
Gross Profit
12.1B INR
Operating Expenses
-6.6B INR
Operating Income
5.5B INR
Other Expenses
-1.3B INR
Net Income
4.2B INR
Fundamental Scores

GLS Profitability Score
Profitability Due Diligence

Glenmark Life Sciences Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROIC
Positive 3-Year Average ROE
Positive Free Cash Flow
61/100
Profitability
Score

Glenmark Life Sciences Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

GLS Solvency Score
Solvency Due Diligence

Glenmark Life Sciences Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Glenmark Life Sciences Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GLS Price Targets Summary
Glenmark Life Sciences Ltd

Wall Street analysts forecast GLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLS is 1 214.41 INR with a low forecast of 797.9 INR and a high forecast of 1 428 INR.

Lowest
Price Target
797.9 INR
28% Downside
Average
Price Target
1 214.41 INR
10% Upside
Highest
Price Target
1 428 INR
30% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GLS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GLS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one GLS stock?

The intrinsic value of one GLS stock under the Base Case scenario is 718.3 INR.

Is GLS stock undervalued or overvalued?

Compared to the current market price of 1 100.6 INR, Glenmark Life Sciences Ltd is Overvalued by 35%.

Back to Top